Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

NCT07461649

Demographic data, medical and medication history, physical examination, 12-lead ECG, haematology, biochemistry, serology, urine routine analysis, additionally for females serum pregnancy test, hormone assay (FSH) will be done within 21 days and a chest X-ray within 06 months prior to check-in. In study period, each group subjects will be housed in the clinical facility for at least -60.00 hours pre-dose to 72.00 hours post-dose.

Bioavailability and Pharmacokinetics

Sichuan Credit Pharmaceutical Co., Ltd.32 participantsStarted Mar 2026

Coimbatore, Tamil Nadu, India

COMPLETEDNA

Silymarin Bioavailability Study

NCT06882681

This study seeks to evaluate and compare the pharmacokinetics of a novel micellar silymarin formulation with that of a standard silymarin formulation.

Bioavailability and Pharmacokinetics

Isura16 participantsStarted May 2024

Burnaby, British Columbia, Canada

Data from ClinicalTrials.govTerms

Showing 1-2 of 2 trials

Not Yet RecruitingNA

Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

NCT07461649

Demographic data, medical and medication history, physical examination, 12-lead ECG, haematology, biochemistry, serology, urine routine analysis, additionally for females serum pregnancy test, hormone assay (FSH) will be done within 21 days and a chest X-ray within 06 months prior to check-in. In study period, each group subjects will be housed in the clinical facility for at least -60.00 hours pre-dose to 72.00 hours post-dose.

Bioavailability and Pharmacokinetics

Sichuan Credit Pharmaceutical Co., Ltd.32 participantsStarted Mar 2026

Coimbatore, Tamil Nadu, India

COMPLETEDNA

Silymarin Bioavailability Study

NCT06882681

This study seeks to evaluate and compare the pharmacokinetics of a novel micellar silymarin formulation with that of a standard silymarin formulation.

Bioavailability and Pharmacokinetics

Isura16 participantsStarted May 2024

Burnaby, British Columbia, Canada

Data from ClinicalTrials.govTerms

Filters

Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

Silymarin Bioavailability Study

Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

Silymarin Bioavailability Study